Organon Launches Two Biosimilars In Canada As Sales Slide

Avastin And Herceptin Rivals Introduced As Biosimilars Turnover Falls In Q3

 
• By Dave Wallace

Organon has launched its Ontruzant trastuzumab biosimilar version of Herceptin and its Aybintio bevacizumab rival to Avastin in Canada. The launches come shortly after the firm revealed biosimilars sales that were slightly down in Q3.

Canada flag two fingers v victory
Organon has introduced two biosimilars in Canada • Source: Shutterstock

More from Products

More from Generics Bulletin